tropisetron
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
149
Go to page
1
2
3
4
5
6
March 04, 2026
Investigation of varenicline and tropisetron in latent inhibition and novel object recognition in mice.
(PubMed, Sci Rep)
- No abstract available
Journal • Preclinical
February 18, 2026
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
(clinicaltrials.gov)
- P3 | N=92 | Recruiting | Sponsor: The Affiliated People's Hospital of Ningbo University
New P3 trial • Bone Marrow Transplantation • Chemotherapy-Induced Nausea and Vomiting • Hematological Malignancies • Multiple Myeloma • Oncology • Transplantation
January 31, 2026
A Randomized Controlled Study of Fumarate Tegileridine versus Sufentanil for Postoperative Analgesia in Abdominal Surgery: A Comparison of Efficacy and Safety
(ChiCTR)
- P1 | N=60 | Not yet recruiting | Sponsor: The Second Affiliated Hospital of Xinjiang Medical University; The Second Affiliated Hospital of Xinjiang Medical University
New P1 trial
January 31, 2026
Optimizing postoperative rehabilitation for female surgical patients: a new treatment strategy for postoperative sleep and pain management
(ChiCTR)
- P=N/A | N=140 | Completed | Sponsor: Xishuangbanna Dai Autonomous Prefecture People's Hospital; Xishuangbanna Dai Autonomous Prefecture People's Hospital | Not yet recruiting ➔ Completed | Phase classification: P4 ➔ PN/A
Phase classification • Trial completion • CNS Disorders • Pain • Sleep Disorder
January 31, 2026
Observation on the Efficacy of Oliceridine for Patient-Controlled Analgesia after Maxillofacial Surgery
(ChiCTR)
- P=N/A | N=210 | Recruiting | Sponsor: Beijing Zhongguancun Hospital; Beijing Zhongguancun Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Pain
January 31, 2026
Comparison of Oliceridine and Hydromorphone for Nausea and Vomiting in Patient-Controlled Intravenous Analgesia After Orthopedic Surgery Under Multimodal Analgesia: A Prospective Cohort Study
(ChiCTR)
- P4 | N=216 | Recruiting | Sponsor: The Second Affiliated Hospital, Zhejiang University School of Medicine; The Second Affiliated Hospital, Zhejiang University School of Medicine
New P4 trial • Orthopedics • Pain
January 31, 2026
nalgesic Efficacy and Effect on Postoperative Delirium of Oliceridine in a Multimodal Analgesia Regimen for Elderly Patients Undergoing Surgery for Hip Fracture: A Multicenter, Randomized, Double-Blind, Controlled Trial
(ChiCTR)
- P4 | N=616 | Not yet recruiting | Sponsor: Henan Provincial People's Hospita,medical; Henan Provincial People's Hospita,medical
New P4 trial • CNS Disorders • Musculoskeletal Diseases • Orthopedics • Pain
January 31, 2026
Evaluation of the Safety and Efficacy of Oliceridine for Postoperative Analgesia in Gynecological Laparoscopic Surgery: A Randomized Controlled Trial
(ChiCTR)
- P4 | N=130 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Xiamen University; The First Affiliated Hospital of Xiamen University
New P4 trial
January 31, 2026
A comparative study on the effects of multimodal analgesia with oliceridine and sufentanil on postoperative rehabilitation of patients undergoing thoracic surgery
(ChiCTR)
- P=N/A | N=94 | Not yet recruiting | Sponsor: Jianyang City People's Hospital; Jianyang City People's Hospital
New trial • Pulmonary Disease • Respiratory Diseases
January 31, 2026
Effect of ultrasound-guided stellate ganglion block on perioperative stress inflammatory factors and postoperative cognitive function in elderly patients with lower limb fractures
(ChiCTR)
- P=N/A | N=160 | Not yet recruiting | Sponsor: The People's Hospital of Shihezi City, Xinjiang; The People's Hospital of Shihezi City
New trial • Cognitive Disorders • Musculoskeletal Diseases • Orthopedics
January 31, 2026
The impact of postoperative analgesia with butorphanol combined with dexmedetomidine on the quality of life in breast cancer patients
(ChiCTR)
- P=N/A | N=94 | Not yet recruiting | Sponsor: Shenzhen Second People's Hospital; Shenzhen Second People's Hospital | Initiation date: Mar 2025 ➔ Nov 2025
Trial initiation date • Breast Cancer • Oncology • Solid Tumor
January 28, 2026
Relationship between perioperative medications and risk of emergence agitation in children after sevoflurane anesthesia: a network meta-analysis.
(PubMed, Pediatr Res)
- "This review provides a detailed network meta-analysis comparing 19 perioperative medications, offering a ranked efficacy profile (via SUCRA analysis) for preventing emergence agitation (EA) in children after sevoflurane anaesthesia, which consolidates and expands upon previous pairwise comparisons. It identifies dexmedetomidine, propofol, midazolam, fentanyl, nalbuphine, and ketamine as the most effective drugs for EA prevention, supporting evidence-based decision-making in paediatric anaesthesia practice."
Journal • Retrospective data • Review • Anesthesia • Pediatrics
January 01, 2026
Repositioning serotonergic antagonists as therapeutic agents in gastric cancer: induction of apoptosis, inhibition of cell migration, and cell cycle arrest in AGS cells.
(PubMed, Cytotechnology)
- "Imipramine induced G1/S phase arrest, whereas tropisetron, ketanserin, and cyproheptadine increased the sub-G1 cell population. Gene expression analysis revealed decreased Bcl-2 and PCNA levels and increased Bax expression.These findings suggest the potential of tropisetron, imipramine, ketanserin, and cyproheptadine as repurposed therapeutic agents for gastric cancer."
IO biomarker • Journal • CNS Disorders • Depression • Gastric Cancer • Oncology • Psychiatry • Solid Tumor • BAX • BCL2 • PCNA • SLC6A4
December 04, 2025
Postoperative delirium in patients with free flap reconstruction after head and neck tumor surgery: influencing factors for severity and onset time, and a prediction model.
(PubMed, BMC Oral Health)
- "POD after head and neck tumor surgery shows marked heterogeneity in severity and onset. Neutrophils and platelets may respectively drive neuroinflammation occurrence and progression, synergizing with blood pressure to regulate POD subtyping. Identified factors enable early multidimensional warning. The prediction model performs well with optimal threshold 0.45-0.55."
Journal • CNS Disorders • Head and Neck Cancer • Oncology • Solid Tumor
December 01, 2025
A Bayesian network meta-analysis of randomized controlled trials comparing the efficacy and safety of cholinergic modulators in schizophrenia.
(PubMed, J Psychopharmacol)
- "Tropisetron and xanomeline demonstrated better efficacy in reducing schizophrenia symptoms, offering a promising alternative to traditional antipsychotics with comparable safety. Further RCTs and NMAs are needed to confirm these findings and guide clinical practice."
Journal • Retrospective data • Review • CNS Disorders • Psychiatry • Schizophrenia
November 28, 2025
Effect of esketamine on postoperative pain relief and depressive status in patients with traumatic fractures.
(PubMed, Front Med (Lausanne))
- P=N/A | "All received a standard postoperative analgesic pump (sufentanil 2 μg/kg + tropisetron 10 mg in 100 ml saline, 1.5 ml/h basal rate, 2 ml PCA bolus, 20 min lockout)...The incidence of postoperative nausea/vomiting was significantly lower in groups L and H compared to group C (P < 0.05). Continuous postoperative infusion of esketamine (0.5-0.75 mg/kg over 24 h) in patients with traumatic lower limb fractures effectively alleviates postoperative depressive symptoms, provides opioid-sparing analgesia, reduces opioid-related adverse effects like nausea and vomiting, and is associated with increased BDNF and decreased IL-6 levels."
Journal • Anesthesia • CNS Disorders • Depression • Musculoskeletal Diseases • Orthopedics • Pain • Psychiatry • BDNF • IL6
October 31, 2025
Observation on the Efficacy of Oliceridine for Patient-Controlled Analgesia after Maxillofacial Surgery
(ChiCTR)
- P=N/A | N=210 | Not yet recruiting | Sponsor: Beijing Zhongguancun Hospital; Beijing Zhongguancun Hospital
New trial • Pain
October 31, 2025
The Effect of Oliceridine versus Hydromorphone on Gastrointestinal Tolerability in Patients Undergoing Major Abdominal Surgery with Multimodal Analgesia: A Prospective, Randomized Controlled Study
(ChiCTR)
- P4 | N=310 | Not yet recruiting | Sponsor: The Second Affiliated Hospital, Zhejiang University School of Medicine; Department of Anesthesiology, the Second Affiliated Hospital, Zhejiang Univers
New P4 trial • Pain
October 31, 2025
Effect of low-dose esketamine on postpartum depression in women undergoing general anesthesia for cesarean delivery: a dual-center, prospective, randomized controlled study
(ChiCTR)
- P=N/A | N=300 | Not yet recruiting | Sponsor: Shanghai First Maternity and Infant Hospital; Shanghai First Maternity and Infant Hospital
New trial • Anesthesia • CNS Disorders • Depression • Mood Disorders • Postpartum Depression • Psychiatry
October 31, 2025
The effect of low-dose esketamine on analgesic and recovery quality after cesarean section: a prospective, randomized, double-blind, controlled clinical trial
(ChiCTR)
- P=N/A | N=120 | Not yet recruiting | Sponsor: The Second Affiliated Hospital of Nanjing Medical University; The Second Affiliated Hospital of Nanjing Medical University
New trial • Pain
October 31, 2025
Clinical study on efficacy and safety of oxalidine fumarate injection for postoperative analgesia in elderly orthopedic patients
(ChiCTR)
- P=N/A | N=165 | Not yet recruiting | Sponsor: Mianyang 404 Hospital (The First People's Hospital Of Mianyang); Mianyang 404 Hospital (The First People's Hospital Of Mianyang)
New trial • Musculoskeletal Diseases • Orthopedics
October 31, 2025
Optimizing postoperative rehabilitation for female surgical patients: a new treatment strategy for postoperative sleep and pain management
(ChiCTR)
- P4 | N=140 | Not yet recruiting | Sponsor: Xishuangbanna Dai Autonomous Prefecture People's Hospital; Xishuangbanna Dai Autonomous Prefecture People's Hospital
New P4 trial • CNS Disorders • Pain • Sleep Disorder
September 27, 2025
Antifibrotic Effects of an α7 Nicotinic Acetylcholine Receptor Agonist in Keloid Fibroblasts and a Rat Scar Model.
(PubMed, Int J Mol Sci)
- "These results indicate that tropisetron exerts dual antifibrotic and anti-inflammatory effects through α7nAChR-mediated signaling and enhanced ECM remodeling. This study provides the first evidence supporting α7nAChR activation as a promising therapeutic strategy for managing keloids and other fibrotic skin disorders."
Journal • Preclinical • Dermatology • Fibrosis • Immunology • Inflammation • COL1A1 • COL3A1 • MMP1 • MMP3 • TGFB1 • TNFA
August 18, 2025
Palonosetron versus tropisetron with dexamethasone for prevention of postoperative nausea and vomiting in pediatric adenotonsillectomy: a single center, randomized controlled trial.
(PubMed, Front Med (Lausanne))
- P4 | "After receiving their allocated drug, children received intravenous dexamethasone (0.15 mg/kg, maximum 5 mg) during induction. In pediatric adenotonsillectomy, palonosetron with dexamethasone gives better PONV prevention than tropisetron with dexamethasone, especially in the first 24 h, with comparable safety. https://www.chictr.org.cn/showproj.html?proj=127115, ChiCTR2100046848."
Journal • Anesthesia • Otorhinolaryngology • Pain • Pediatrics
August 27, 2025
Effects of Glycopyrronium Bromide as an Adjuvant Treatment in the Prevention of Nausea and Vomiting After Abdominal, Thyroid, and Breast Surgery: A Multicenter Randomized Controlled Trial.
(PubMed, Drug Des Devel Ther)
- P4 | "In 11 participating hospitals, patients who were scheduled to receive gynecological (n=123), gastrointestinal (n=201), thyroid (n=93), and breast surgery (n=51) under general anesthesia and received postoperative opioids were randomly allocated to receive 4 mg dexamethasone and 4 mg tropisetron (Group C) or 4 mg dexamethasone and 4 mg tropisetron combined with 0.2 mg glycopyrrolate bromide (Group G). The Hospital Ethics Committee of the Second Affiliated Hospital, Chongqing Medical University (Approval ID: 2022-14-1) approved this study. This trial was registered with Identifier NCT05331651 on ClinicalTrials.gov."
Clinical • Journal • Anesthesia
1 to 25
Of
149
Go to page
1
2
3
4
5
6